Abstract
Insulin resistance (IR) is one of main causes of metabolic syndrome (Mets), which is clustered with several risk factors for cardiovascular disease. IR is also main cause of essential hypertension (EHT) as well as activation of renin-angiotensin-aldosterone system (RAAS), sympathetic nervous system (SNS) and salt-sensitivity. Recent researches reveal that IR is closely linked with RAAS, SNS and salt sensitivity especially in subjects with obesity. Unbalanced regulation of adipocytokines is also playing an important role on the progression of IR. In this review paper, we reviewed a role of IR in pathogenesis of EHT and therapeutic approaches to EHT with obesity or Mets targeting on the IR.
Keywords: Insulin resistance, Hypertension, Metabolic syndrome, RAAS, SNS, Salt sensitivity, obesity, Adiponectin, hyperadiponectinemia
Current Hypertension Reviews
Title: Insulin Resistance and Hypertension
Volume: 7 Issue: 3
Author(s): Ken Sugimoto, Kei Kamide and Hiromi Rakugi
Affiliation:
Keywords: Insulin resistance, Hypertension, Metabolic syndrome, RAAS, SNS, Salt sensitivity, obesity, Adiponectin, hyperadiponectinemia
Abstract: Insulin resistance (IR) is one of main causes of metabolic syndrome (Mets), which is clustered with several risk factors for cardiovascular disease. IR is also main cause of essential hypertension (EHT) as well as activation of renin-angiotensin-aldosterone system (RAAS), sympathetic nervous system (SNS) and salt-sensitivity. Recent researches reveal that IR is closely linked with RAAS, SNS and salt sensitivity especially in subjects with obesity. Unbalanced regulation of adipocytokines is also playing an important role on the progression of IR. In this review paper, we reviewed a role of IR in pathogenesis of EHT and therapeutic approaches to EHT with obesity or Mets targeting on the IR.
Export Options
About this article
Cite this article as:
Sugimoto Ken, Kamide Kei and Rakugi Hiromi, Insulin Resistance and Hypertension, Current Hypertension Reviews 2011; 7 (3) . https://dx.doi.org/10.2174/1573402111107030137
DOI https://dx.doi.org/10.2174/1573402111107030137 |
Print ISSN 1573-4021 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6506 |
Call for Papers in Thematic Issues
Arterial Stiffness in hypertension and left ventricular dysfunction, PWV, Heart Failure
Large artery (aortic) stiffening has important consequences on cardiovascular health, including isolated systolic hypertension, excessive penetration of pulsatile energy into the microvasculature of target organs that operate at low vascular resistance, and abnormal ventricular-arterial interactions that promote left ventricular remodeling, dysfunction and failure. Large artery stiffness independently predicts cardiovascular risk ...read more
Pediatric Hypertension
Scope: This special feature focuses on the latest research and clinical advances in the field of pediatric hypertension. We welcome original research papers, review articles, case reports, as well as technical and methodological discussions from academia and clinical practitioners worldwide. Topics of interest include but are not limited to: Epidemiology ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Rheumatoid Foot and Ankle Surgery
Current Rheumatology Reviews Physiological Significance and Therapeutic Potential of Adrenomedullin in Pulmonary Hypertension
Cardiovascular & Hematological Disorders-Drug Targets Oxidative Stress and Mitochondrial Impairment After Treatment with Anti-HIV Drugs: Clinical Implications
Current Pharmaceutical Design Targeting Angiogenesis in Thyroid Cancer
Current Angiogenesis (Discontinued) Diagnoses of Gastrointestinal Cancers After Gastrointestinal Bleeding in Patients Receiving Clopidogrel or Warfarin
Current Drug Safety Cyclooxygenase-2 and Prostaglandin E2 are Associated with Middle Cerebral Artery Occlusion and Hemorrhage in Patients with Moyamoya Disease
Current Neurovascular Research Central Hemodynamics for Risk Reduction Strategies: Additive Value Over and Above Brachial Blood Pressure
Current Pharmaceutical Design The Renin-Angiotensin System: New Insight into Old Therapies
Current Medicinal Chemistry U-Shaped Association Between Serum Uric Acid and Hemorrhagic Transformation After Intravenous Thrombolysis
Current Neurovascular Research Coffee to Reduce Risk of Type 2 Diabetes? : A Systematic Review
Current Diabetes Reviews Etanercept Improves Cognitive Performance and Increases eNOS and BDNF Expression During Experimental Vascular Dementia in Streptozotocin- induced Diabetes
Current Neurovascular Research Neurovascular Mechanisms of Hypertension in Pregnancy
Current Neurovascular Research Alzheimers and Dementia in the Oldest-Old: A Century of Challenges
Current Alzheimer Research Gender Differences in Aminoglycoside Induced Nephrotoxicity: A Prospective, Hospital - Based Study
Current Clinical Pharmacology The Clinical Characteristics and Survival Profiles of Wilms Tumor in the United Arab Emirates: A Single-center Retrospective Analysis
New Emirates Medical Journal Comparison of Status Epilepticus Models Induced by Pilocarpine and Nerve Agents - A Systematic Review of the Underlying Aetiology and Adopted Therapeutic Approaches
Current Medicinal Chemistry Bone Mineral Density in Type 2 Diabetes Patients with Charcot Arthropathy
Current Diabetes Reviews Inflammation and Anemia
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Lipids: A Major Culprit in Diabetic Nephropathy
Current Diabetes Reviews Correlation of Urine Biomarkers: Microalbuminuria and Spot Urine Protein among Diabetic Patients. Application of Spot Urine Protein in Diabetic Kidney Disease, Nephropathy, Proteinuria Estimation, Diagnosing and Monitoring
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)